NEW YORK, Nov. 16, 2016 /PRNewswire/ -- The global Molecular Diagnostics market is projected to reach USD 9.9billion by the end of 2021, growing with a CAGR of 9.4% from 2016 to 2021. Molecular diagnostics helps in the early detection of cancer, genetic disorders, and other infectious diseases.New technology has enabled instruments to offer fast and accurate test results. This ability of the diagnostic tool has resulted in a rapid rise in penetration levels especially, in the point of care facilities. Molecular diagnostics has also given rise to the concept of personalized medicine.Growing prevalence of infectious diseases and hospital acquired infections are expected to drive market growth during the forecast period.Increasing demand for point of care facilities boosts the molecular diagnostics industry growth majorly due to rising demand for quick and remote healthcare delivery. Segments Covered:The report segments the global Molecular Diagnostics market by products & services, technology, end user, application, and region. The products & services include instruments, reagents, and services & software. Similarly, the technologies include Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Hybridization [In Situ Hybridization & Fluorescent In Situ Hybridization (FISH)], DNA Sequencing and Next-generation Sequencing, Microarrays and Others (Mass Spectrometry, Flow Cytometry, and Electrophoresis), whereas the end users include reference laboratories, hospital laboratories, others. The application covered in the report include infectious diseases, oncology, genetics, blood screening, microbiology, and others. Geographic Coverage and Analysis: The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. Among the various regions covered, North America dominated the global Molecular Diagnostics market whereas on the basis of countries, U.S. is projected to dominate the global Molecular Diagnostics market. Companies profiled:The companies covered in the report include Aspen Molecular Diagnostics Inc. (U.S.), Cabot Corporation (U.S.), Molecular Diagnostics Technologies LLC (U.S.), Nano High-Tech Co. Ltd. ( China), Guangdong Alison Hi-Tech Co. Ltd. ( China), Active Molecular Diagnostics ( Portugal), Enersens SAS ( France), JIOS Molecular Diagnostics Corporation ( South Korea) and BASF SE ( Germany). Report Highlights:The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand ofMolecular Diagnostics globally as well as regionally. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and value chain analysis ofMolecular Diagnostics. Moreover, the study highlights current market trends and provides forecast from 2016 to 2021. We also have highlighted future trends in theMolecular Diagnostics market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. Additionally, the analysis highlights rise and fall in the market shares of the key players in the market. This report will help manufacturers, suppliers and distributors of the Molecular Diagnostics market to understand the present and future trends in this market and formulate their strategies accordingly.